Table 2.

Sero-prevalences of HSV type 1 and 2 according to cancer history-NHANES 1999–2014

Variable	Status	HSV1+ number	HSV1- number	HSV1+ weighted percent	s.e.	P value
Any cancer	Yes	229	93	67.17	3.12	0.04
	No	5231	2631	60.39	0.91
Breast cancer	Yes	24	8	76.16	8.44	0.11
	No	5436	2716	60.65	0.90
Cervical cancer	Yes	88	40	65.23	5.75	0.44
	No	5372	2684	60.64	0.90
Ovarian cancer	Yes	21	3	77.82	11.77	0.22
	No	5439	2721	60.68	0.90
Uterine cancer	Yes	30	4	92.24	4.51	<0.01
	No	5430	2720	60.61	0.90
Variable	Status	HSV2+ number	HSV2- number	HSV2+ weighted percent	s.e.	P value
Any cancer	Yes	119	203	34.26	3.51	<0.01
	No	2144	5718	24.54	0.66
Breast cancer	Yes	8	24	23.64	9.23	0.88
	No	2255	5897	25.02	0.64
Cervical cancer	Yes	56	72	40.05	5.41	<0.01
	No	2207	5849	24.74	0.65
Ovarian cancer	Yes	11	13	44.41	12.95	0.09
	No	2252	5908	24.96	0.65
Uterine cancer	Yes	15	19	57.99	11.61	<0.01
	No	2248	5902	24.89	0.65

Abbreviations: HSV1, herpes simplex virus type 1; HSV2, herpes simplex virus type 2; +, positive; −, negative; s.e., standard error; NHANES, National Health and Nutrition Examination Survey